ジェノタイピングの世界市場レポート 2025年

ジェノタイピングの市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR17.9％で514億3,000万米ドルに成長します。予測期間の成長は、臨床診断における採用の増加、個別化医療に対する需要の高まり、研究開発イニシアチブの上昇、農業および家畜におけるアプリケーションの拡大に起因しています。予測期間の主な動向には、薬理ゲノミクス需要の増加、次世代シーケンシング（ngs）の進歩、精密医療イニシアティブの拡大、消費者直接（dtc）遺伝子検査の成長、がんゲノミクスと個別化治療への注力などがあります。

がんと遺伝性疾患の罹患率の増加は、今後数年間のジェノタイピング市場の成長を促進すると予想されます。がんは、体内のほぼすべての臓器や組織で発症する可能性のある広範な疾患を包含し、遺伝子疾患は典型的なDNA配列の逸脱から発生します。ジェノタイピングによって、科学者は一塩基の変異、コピー数の変異、DNAの重大な構造変化を含む遺伝的変異を調べることができます。この遺伝子検査は、特定のがんの発症リスクを高める可能性のある特定の遺伝子変異を特定しようとするものです。例えば、2024年2月、スイスに本部を置く国際的な公衆衛生に重点を置く機関である世界保健機関（WHO）は、2022年には約2,000万人のがん患者が新たに発生し、970万人が死亡したと報告しました。さらに、がんと診断されてから5年後に生存していた人の数は推定5,350万人でした。さらに2023年2月、英国を拠点とする登録慈善団体ジーン・ピープルUKは、子どもの25人に1人が遺伝性疾患を有しており、英国では毎年約3万人が新たに乳幼児と子どもに遺伝性疾患の診断を受け、240万人以上の子どもと成人が遺伝性疾患とともに生活していると推定しました。その結果、がんと遺伝性疾患の有病率の増加がジェノタイピング市場を前進させています。

遺伝子検査に対する需要の高まりも、ジェノタイピング市場の成長に寄与すると予想されます。個人のDNAを分析して変異や突然変異を特定する遺伝子検査は、遺伝的差異に関する具体的な情報を提供するジェノタイピングに依存しています。遺伝子検査の利用は、2022年11月に前年比15％増と顕著な伸びを示し、検査室検査全体の約10％を占め、成長傾向を示しています。このような遺伝子検査需要の急増が、ジェノタイピング市場の成長をさらに後押ししています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のジェノタイピング PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のジェノタイピング市場：成長率分析
• 世界のジェノタイピング市場の実績：規模と成長, 2019-2024
• 世界のジェノタイピング市場の予測：規模と成長, 2024-2029, 2034F
• 世界のジェノタイピング総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のジェノタイピング市場：製品・サービス別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 機器
• 試薬とキット
• バイオインフォマティクス
• ジェノタイピングサービス
• 世界のジェノタイピング市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• マイクロアレイ
• キャピラリー電気泳動
• シーケンシング
• ポリメラーゼ連鎖反応
• マトリックス支援レーザー脱離またはイオン化（MALDI-TOF）質量分析法
• その他の技術
• 世界のジェノタイピング市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 薬理ゲノム学
• 診断と個別化医療
• 動物遺伝学
• 農業バイオテクノロジー
• その他の用途
• 世界のジェノタイピング市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 製薬・バイオ医薬品企業
• 診断および研究ラボ
• 学術機関
• その他のエンドユーザー
• 世界のジェノタイピング市場、タイプ別サブセグメンテーション：機器、実績と予測, 2019-2024, 2024-2029F, 2034F
• シーケンサー
• PCRマシン
• マイクロアレイ
• ジェノタイピングプラットフォーム
• 世界のジェノタイピング市場、タイプ別サブセグメンテーション：試薬とキット、実績と予測, 2019-2024, 2024-2029F, 2034F
• DNA抽出キット
• PCR試薬
• SNPジェノタイピングキット
• 次世代シーケンシング（NGS）キット
• 世界のジェノタイピング市場、タイプ別サブセグメンテーション：バイオインフォマティクス、実績と予測, 2019-2024, 2024-2029F, 2034F
• データ分析ソフトウェア
• ゲノムデータ管理ツール
• クラウドベースのソリューション
• 世界のジェノタイピング市場、タイプ別サブセグメンテーション：ジェノタイピングサービス、実績と予測, 2019-2024, 2024-2029F, 2034F
• 研究受託機関（CRO）サービス
• カスタムジェノタイピングサービス
• サンプル調製サービス

第7章 地域別・国別分析

• 世界のジェノタイピング市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のジェノタイピング市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ジェノタイピング市場：競合情勢
• ジェノタイピング市場：企業プロファイル
  • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis
  • Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis
  • Agilent Technologies Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• PerkinElmer Inc.
• Illumina Inc.
• Bio-Rad Laboratories Inc.
• QIAGEN NV
• BGI Genomics
• LGC Biosearch Technologies
• GenScript Biotech
• Inotiv
• Takara Bio Inc.
• Integrated DNA Technologies Ltd.
• 23andMe Inc.
• Novogene Corporation
• Oxford Nanopore Technologies
• Macrogen Inc.
• Pacific Biosciences of California

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• ジェノタイピング市場2029：新たな機会を提供する国
• ジェノタイピング市場2029：新たな機会を提供するセグメント
• ジェノタイピング市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Genotyping is a laboratory procedure that involves examining an individual's germline DNA to identify specific variations in nucleotides or bases. Researchers utilize genotyping to explore genetic variants, including single nucleotide variations, copy number variations, and substantial structural alterations in DNA. This technique finds applications in diverse fields such as agriculture, medicine, and basic science.

The primary categories of genotyping products and services encompass instruments, reagents and kits, bioinformatics, and genotyping services. An instrument is a tool designed to measure various parameters, such as speed, height, or sound. In the context of genotyping, instruments are employed to investigate genetic variations such as significant structural alterations in DNA, copy number variations, and single nucleotide variations. Various technologies are incorporated, including microarrays, capillary electrophoresis, sequencing, polymerase chain reaction, matrix-assisted laser desorption or ionization (Maldi-TOF) mass spectrometry, and other technologies. These technologies serve multiple applications, including pharmacogenomics, diagnostics, personalized medicine, animal genetics, agricultural biotechnology, among others. The end-users of genotyping products and services include pharmaceutical and biopharmaceutical companies, diagnostics and research laboratories, academic institutes, and others.

The genotyping market research report is one of a series of new reports from The Business Research Company that provides genotyping market statistics, including genotyping industry global market size, regional shares, competitors with a genotyping market share, detailed genotyping market segments, market trends and opportunities, and any further data you may need to thrive in the genotyping industry. This genotyping market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The genotyping market size has grown rapidly in recent years. It will grow from $23.04 billion in 2024 to $26.63 billion in 2025 at a compound annual growth rate (CAGR) of 15.6%. The growth in the historic period can be attributed to government initiatives and funding, rapid decline in genotyping costs, expansion of biobanks and genetic databases, increasing prevalence of genetic disorders, pharmacogenomics and drug development

The genotyping market size is expected to see rapid growth in the next few years. It will grow to $51.43 billion in 2029 at a compound annual growth rate (CAGR) of 17.9%. The growth in the forecast period can be attributed to increased adoption in clinical diagnostics, growing demand for personalized medicine, rise in research and development initiatives, expanding application in agriculture and livestock. Major trends in the forecast period include rise in demand for pharmacogenomics, advancements in next-generation sequencing (ngs), expansion in precision medicine initiatives, growth in direct-to-consumer (dtc) genetic testing, focus on cancer genomics and personalized therapies.

The rising incidence of cancer and genetic disorders is anticipated to drive growth in the genotyping market in the coming years. Cancer encompasses a wide range of diseases that can initiate in nearly any organ or tissue within the body, while genetic disorders arise from deviations in the typical DNA sequence. Genotyping enables scientists to examine genetic variations, including single nucleotide variations, copy number variations, and significant structural changes in DNA. This form of genetic testing seeks to identify specific gene mutations that may increase an individual's risk of developing certain cancers. For example, in February 2024, the World Health Organization, a Switzerland-based agency focused on international public health, reported that in 2022, there were approximately 20 million new cancer cases, leading to 9.7 million deaths. Additionally, an estimated 53.5 million individuals were alive five years post-cancer diagnosis. Furthermore, in February 2023, Gene People UK, a UK-based registered charity, estimated that 1 in 25 children has a hereditary condition, equating to around 30,000 new diagnoses of hereditary conditions in babies and children annually in the UK, and over 2.4 million children and adults living with a genetic disorder. Consequently, the growing prevalence of cancer and genetic disorders is propelling the genotyping market forward.

The increasing demand for genetic testing is also expected to contribute to the growth of the genotyping market. Genetic testing, involving the analysis of an individual's DNA to identify variations or mutations, relies on genotyping to provide specific information about genetic differences. The utilization of genetic testing witnessed a notable 15% increase in November 2022 compared to the previous year, constituting approximately 10% of all lab tests and indicating a growing trend. This surge in demand for genetic testing further propels the growth of the genotyping market.

Innovations in product offerings are a prominent trend gaining traction in the genotyping market. Companies within the genotyping sector are embracing inventive solutions to maintain their competitive positions. A notable example is the collaboration between Neogen, a US-based food safety company, and Gencove Inc., a US-based provider of a sequencing platform for genome discovery, leading to the introduction of InfiniSEEK in May 2022. This groundbreaking and cost-effective solution revolutionizes whole genome sequencing and targeted SNP (single nucleotide polymorphism) analysis, particularly catering to cattle breeders. InfiniSEEK provides a platform for managing over 400 bovine genetic characteristics, identifying new variables affecting desirable phenotypes, and mitigating selection bias by sequencing larger populations or the entire population. This unique service empowers consumers with a data-rich, cost-effective approach to globally profile cattle, integrating genome-wide sequencing data, specific genetic traits, and parentage markers.

Major players in the genotyping market are directing their focus toward the development of cutting-edge solutions, exemplified by the emphasis on high-coverage whole genome sequencing. This advanced genetic sequencing technique involves a comprehensive analysis of an individual's entire genome with high coverage. A notable initiative in this direction is the collaboration between Gencove, a US-based software company, and NEOGEN Corporation, a US-based food safety company, leading to the launch of InfiniSEEK in May 2022. This groundbreaking and cost-efficient solution enables the simultaneous execution of low-pass whole genome sequencing and high-coverage genotyping in specific regions of interest.

In April 2022, LGC, a life sciences company based in the UK, acquired Rapid Genomics for an undisclosed sum. This acquisition is intended to strengthen LGC's position in the agrigenomics market by incorporating Rapid Genomics' Next-Generation Sequencing (NGS) technology and services. Rapid Genomics, a biotechnology firm located in the US, specializes in offering NGS kits and services for genotyping.

Major companies operating in the genotyping market include F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Eurofins Scientific SE, Agilent Technologies, PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN NV, BGI Genomics, LGC Biosearch Technologies, GenScript Biotech, Inotiv, Takara Bio Inc., Integrated DNA Technologies Ltd., 23andMe Inc., Novogene Corporation, Oxford Nanopore Technologies, Macrogen Inc., Pacific Biosciences of California, Standard BioTools Inc., GENEWIZ, Transnetyx, Agena Bioscience Inc., Genotypic Technology Pvt Ltd., BMG LABTECH GmbH, Bioline, Biofortuna Limited, Xcelris Genomics

North America was the largest region in genotyping market in 2024. The regions covered in the genotyping market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the genotyping market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The genotyping market consists of revenues earned by entities by providing services such as custom genotyping services, genetic counselling, genotyping assay services, Sanger sequencing, fragment length analysis, and genotyping data analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The genotyping market also includes sales of thermal cyclers, PCR (polymerase chain reaction) systems, fully integrated microarray instrument, which are used in providing genotyping services. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Genotyping Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on genotyping market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for genotyping ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The genotyping market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product And Services: Instruments; Reagents And Kits; Bioinformatics; Genotyping Service
• 2) By Technology: Microarrays; Capillary Electrophoresis; Sequencing; Polymerase Chain Reaction; Matrix-Assisted Laser Desorption Or Ionization (Maldi-Tof) Mass Spectrometry; Other Technologies
• 3) By Application: Pharmacogenomics; Diagnostics And Personalized Medicine; Animal Genetics; Agricultural Biotechnology; Other Applications
• 4) By End-User: Pharmaceutical And Biopharmaceutical Companies; Diagnostics And Research Laboratories; Academic Institutes; Other End-Users
• Subsegments:
• 1) By Instruments: Sequencers; PCR Machines; Microarrays; Genotyping Platforms
• 2) By Reagents And Kits: DNA Extraction Kits; PCR Reagents; SNP Genotyping Kits; Next-Generation Sequencing (NGS) Kits
• 3) By Bioinformatics: Data Analysis Software; Genomic Data Management Tools; Cloud-based Solutions
• 4) By Genotyping Services: Contract Research Organizations (CRO) Services; Custom Genotyping Services; Sample Preparation Services
• Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Laboratory Corporation of America Holdings; Eurofins Scientific SE; Agilent Technologies
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Genotyping Market Characteristics

3. Genotyping Market Trends And Strategies

4. Genotyping Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Genotyping Growth Analysis And Strategic Analysis Framework

• 5.1. Global Genotyping PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Genotyping Market Growth Rate Analysis
• 5.4. Global Genotyping Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Genotyping Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Genotyping Total Addressable Market (TAM)

6. Genotyping Market Segmentation

• 6.1. Global Genotyping Market, Segmentation By Product and Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Instruments
• Reagents and Kits
• Bioinformatics
• Genotyping Service
• 6.2. Global Genotyping Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Microarrays
• Capillary Electrophoresis
• Sequencing
• Polymerase Chain Reaction
• Matrix-Assisted Laser Desorption or Ionization (MALDI-TOF) Mass Spectrometry
• Other Technologies
• 6.3. Global Genotyping Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmacogenomics
• Diagnostics and Personalized Medicine
• Animal Genetics
• Agricultural Biotechnology
• Other Applications
• 6.4. Global Genotyping Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical and Biopharmaceutical Companies
• Diagnostics and Research Laboratories
• Academic Institutes
• Other End-Users
• 6.5. Global Genotyping Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sequencers
• PCR Machines
• Microarrays
• Genotyping Platforms
• 6.6. Global Genotyping Market, Sub-Segmentation Of Reagents And Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• DNA Extraction Kits
• PCR Reagents
• SNP Genotyping Kits
• Next-Generation Sequencing (NGS) Kits
• 6.7. Global Genotyping Market, Sub-Segmentation Of Bioinformatics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Data Analysis Software
• Genomic Data Management Tools
• Cloud-based Solutions
• 6.8. Global Genotyping Market, Sub-Segmentation Of Genotyping Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Contract Research Organizations (CRO) Services
• Custom Genotyping Services
• Sample Preparation Services

7. Genotyping Market Regional And Country Analysis

• 7.1. Global Genotyping Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Genotyping Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Genotyping Market

• 8.1. Asia-Pacific Genotyping Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Genotyping Market, Segmentation By Product and Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Genotyping Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Genotyping Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Genotyping Market

• 9.1. China Genotyping Market Overview
• 9.2. China Genotyping Market, Segmentation By Product and Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Genotyping Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Genotyping Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Genotyping Market

• 10.1. India Genotyping Market, Segmentation By Product and Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Genotyping Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Genotyping Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Genotyping Market

• 11.1. Japan Genotyping Market Overview
• 11.2. Japan Genotyping Market, Segmentation By Product and Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Genotyping Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Genotyping Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Genotyping Market

• 12.1. Australia Genotyping Market, Segmentation By Product and Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Genotyping Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Genotyping Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Genotyping Market

• 13.1. Indonesia Genotyping Market, Segmentation By Product and Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Genotyping Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Genotyping Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Genotyping Market

• 14.1. South Korea Genotyping Market Overview
• 14.2. South Korea Genotyping Market, Segmentation By Product and Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Genotyping Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Genotyping Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Genotyping Market

• 15.1. Western Europe Genotyping Market Overview
• 15.2. Western Europe Genotyping Market, Segmentation By Product and Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Genotyping Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Genotyping Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Genotyping Market

• 16.1. UK Genotyping Market, Segmentation By Product and Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Genotyping Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Genotyping Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Genotyping Market

• 17.1. Germany Genotyping Market, Segmentation By Product and Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Genotyping Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Genotyping Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Genotyping Market

• 18.1. France Genotyping Market, Segmentation By Product and Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Genotyping Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Genotyping Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Genotyping Market

• 19.1. Italy Genotyping Market, Segmentation By Product and Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Genotyping Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Genotyping Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Genotyping Market

• 20.1. Spain Genotyping Market, Segmentation By Product and Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Genotyping Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Genotyping Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Genotyping Market

• 21.1. Eastern Europe Genotyping Market Overview
• 21.2. Eastern Europe Genotyping Market, Segmentation By Product and Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Genotyping Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Genotyping Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Genotyping Market

• 22.1. Russia Genotyping Market, Segmentation By Product and Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Genotyping Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Genotyping Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Genotyping Market

• 23.1. North America Genotyping Market Overview
• 23.2. North America Genotyping Market, Segmentation By Product and Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Genotyping Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Genotyping Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Genotyping Market

• 24.1. USA Genotyping Market Overview
• 24.2. USA Genotyping Market, Segmentation By Product and Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Genotyping Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Genotyping Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Genotyping Market

• 25.1. Canada Genotyping Market Overview
• 25.2. Canada Genotyping Market, Segmentation By Product and Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Genotyping Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Genotyping Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Genotyping Market

• 26.1. South America Genotyping Market Overview
• 26.2. South America Genotyping Market, Segmentation By Product and Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Genotyping Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Genotyping Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Genotyping Market

• 27.1. Brazil Genotyping Market, Segmentation By Product and Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Genotyping Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Genotyping Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Genotyping Market

• 28.1. Middle East Genotyping Market Overview
• 28.2. Middle East Genotyping Market, Segmentation By Product and Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Genotyping Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Genotyping Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Genotyping Market

• 29.1. Africa Genotyping Market Overview
• 29.2. Africa Genotyping Market, Segmentation By Product and Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Genotyping Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Genotyping Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Genotyping Market Competitive Landscape And Company Profiles

• 30.1. Genotyping Market Competitive Landscape
• 30.2. Genotyping Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Agilent Technologies Overview, Products and Services, Strategy and Financial Analysis

31. Genotyping Market Other Major And Innovative Companies

• 31.1. PerkinElmer Inc.
• 31.2. Illumina Inc.
• 31.3. Bio-Rad Laboratories Inc.
• 31.4. QIAGEN NV
• 31.5. BGI Genomics
• 31.6. LGC Biosearch Technologies
• 31.7. GenScript Biotech
• 31.8. Inotiv
• 31.9. Takara Bio Inc.
• 31.10. Integrated DNA Technologies Ltd.
• 31.11. 23andMe Inc.
• 31.12. Novogene Corporation
• 31.13. Oxford Nanopore Technologies
• 31.14. Macrogen Inc.
• 31.15. Pacific Biosciences of California

32. Global Genotyping Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Genotyping Market

34. Recent Developments In The Genotyping Market

35. Genotyping Market High Potential Countries, Segments and Strategies

• 35.1 Genotyping Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Genotyping Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Genotyping Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer